News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Three Penn Medicine Faculty Members Make Forbes List of 250 of America’s Greatest Innovators
They were recognized for developing groundbreaking ideas and businesses that transformed society.
A New Hub for AI-Driven RNA Research Opens at Penn
Penn’s newest collaborative institution is the U.S. National Science Foundation Artificial Intelligence-driven RNA BioFoundry (NSF AIRFoundry), which uses AI to improve, accelerate, and scale the desi
Federal Small Business Programs Reauthorized
The Small Business Innovation and Economic Security Act reauthorized and updated the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs.
Top 10 U.S. Biopharma Clusters 2026 ranks Philadelphia #5
The region rose two spots this year and was recognized for growth in lab space, NIH funding, venture capital, patent rankings, and industry attraction.
Penn Ranks #3 in Cure Healthcare Innovation Index
The index evaluates how effectively institutions turn scientific research into real-world medical and commercial impact.
Vasowatch Seeks FDA Clearance for Postpartum Prediction Tools
The company is developing predictive software that transforms existing wearables into early-warning tools for postpartum hemorrhage.
New Clinical Data Move Cabaletta Closer to First Autoimmune CAR-T Approval
The company reported encouraging clinical data for its CAR T-cell therapy, RESE-CEL™.
Vivodyne and Opus Genetics Named Most Innovative Biotech Companies of 2026 by Fast Company
The companies are spun out of Penn Engineering and Penn Medicine, respectively.
GemmaBio Joins Lilly Gateway Labs as First Tenant
GemmaBio was co-founded by Penn Medicine Emeritus Professor James M. Wilson, MD, PhD.